DnB Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Hold |
12,767
| – | – | 0.01% | 509 |
|
|
2025
Q1 | $2.86M | Sell |
12,767
-25
| -0.2% | -$5.6K | 0.01% | 500 |
|
|
2024
Q4 | $4.19M | Buy |
12,792
+332
| +3% | +$109K | 0.02% | 416 |
|
|
2024
Q3 | $3.74M | Buy |
12,460
+809
| +7% | +$243K | 0.02% | 438 |
|
|
2024
Q2 | $3.84M | Buy |
11,651
+590
| +5% | +$194K | 0.02% | 397 |
|
|
2024
Q1 | $4.38M | Sell |
11,061
-3,958
| -26% | -$1.57M | 0.02% | 375 |
|
|
2023
Q4 | $5.29M | Sell |
15,019
-203
| -1% | -$71.5K | 0.03% | 351 |
|
|
2023
Q3 | $5.71M | Buy |
15,222
+247
| +2% | +$92.7K | 0.03% | 325 |
|
|
2023
Q2 | $5.73M | Buy |
14,975
+18
| +0.1% | +$6.88K | 0.03% | 332 |
|
|
2023
Q1 | $5.18M | Buy |
14,957
+515
| +4% | +$178K | 0.03% | 355 |
|
|
2022
Q4 | $3.4M | Sell |
14,442
-67
| -0.5% | -$15.8K | 0.02% | 418 |
|
|
2022
Q3 | $3.57M | Sell |
14,509
-433
| -3% | -$107K | 0.03% | 398 |
|
|
2022
Q2 | $4.52M | Buy |
14,942
+443
| +3% | +$134K | 0.03% | 357 |
|
|
2022
Q1 | $5.95M | Buy |
14,499
+1,417
| +11% | +$582K | 0.04% | 335 |
|
|
2021
Q4 | $6.14M | Sell |
13,082
-263
| -2% | -$123K | 0.04% | 329 |
|
|
2021
Q3 | $5.67M | Buy |
13,345
+162
| +1% | +$68.8K | 0.04% | 328 |
|
|
2021
Q2 | $4.73M | Buy |
13,183
+1,236
| +10% | +$444K | 0.03% | 380 |
|
|
2021
Q1 | $3.37M | Buy |
11,947
+850
| +8% | +$240K | 0.02% | 421 |
|
|
2020
Q4 | $3.14M | Buy |
11,097
+219
| +2% | +$62K | 0.03% | 362 |
|
|
2020
Q3 | $2.99M | Buy |
+10,878
| New | +$2.99M | 0.03% | 317 |
|
|
2020
Q2 | – | Sell |
-11,074
| Closed | -$1.69M | – | 627 |
|
|
2020
Q1 | $1.69M | Sell |
11,074
-1,263
| -10% | -$192K | 0.02% | 378 |
|
|
2019
Q4 | $1.85M | Buy |
+12,337
| New | +$1.85M | 0.02% | 472 |
|